In contrast, in gastric cancer, patients with high HHLA2 mRNA levels in peripheral blood have a higher 5-year survival rate than those with low HHLA2 levels, and HHLA2 mRNA levels have a significant negative association with invasive tumour behaviours [18]. This evidence concerns the gene HHLA2 and gastric cancer.